Business

CAI International, Inc. Stockholders Approve Merger Agreement for Acquisition by Mitsubishi HC Capital Inc.

SAN FRANCISCO--(BUSINESS WIRE)-- CAI International, Inc. (NYSE: CAI) (“CAI” or the “Company”), one of the world’s leading transportation finance companies,

articleCaris Life Sciences, Inc.September 2, 20213/company/caris-life-sciences-inc-common-stock/news/cai-international-inc-stockholders-approve-merger-agreement-for-acquisition-by
CAI International, Inc. Stockholders Approve Merger Agreement for Acquisition by Mitsubishi HC Capital Inc.

About this update from Caris Life Sciences, Inc.

[{"type":"text","content":" SAN FRANCISCO--(BUSINESS WIRE)--\nCAI International, Inc. (NYSE: CAI) (“CAI” or the “Company”), one of the world’s leading transportation finance companies, announced today that the Company’s common stockholders, at a special meeting of the Company’s common stockholders held earlier today (the “Special Meeting”), voted to adopt the previously announced merger agreement for the acquisition of the Company by Mitsubishi HC Capital Inc. (“MHC”). Under the terms of the merger agreement, the Company’s common stockholders will be entitled to receive $56.00 per share in cash at the closing of the acquisition. The transaction is expected to close in the late third quarter or early fourth quarter of 2021.\n\nUpon completion of the acquisition, CAI will become privately held as a wholly-owned subsidiary of MHC.\n\nAccording to the final voting results, approximately 75% of the Company’s outstanding shares of common stock were cast, as of the close of business on August 2, 2021, the record date for the Special Meeting, with approximately 99% of the votes cast voting in favor of the merger agreement.\n\nThe consummation of the merger remains subject to the satisfaction or waiver of certain other closing conditions set forth in the merger agreement (including completion of the Migration (as defined in the merger agreement)) and discussed in detail in the definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission (“SEC”) by the Company on August 4, 2021 (as supplemented, the “Definitive Proxy Statement”).\n\nAbout CAI International, Inc.\n\nCAI is one of the world’s leading transportation finance companies. As of June 30, 2021, CAI operated a worldwide fleet of approximately 1.9 million CEUs of containers. CAI operates through 13 offices located in 12 countries including the United States.\n\nForward-Looking Statements\n\nThis communication includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Exchange Act of 1934, as amended. All statements included in this communication, other than statements of historical fact, are forward-looking statements. Statements about the expected timing, completion and effects of the proposed merger and related transactions and all other statements in this communication, other than historical facts, ...

More updates from Caris Life Sciences, Inc.